Madison Birdno
Family Health · Jonesboro, ARNPI 1114534369
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 35.3% of the total. Reporting peaked in 2023 at $419 and has fallen 95.8% since, to $18 in 2025.
Across 39 payments — averaging $21.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$295
- Lilly USA, LLC$123
- Takeda Pharmaceuticals U.S.A., Inc.$70
- GSK$51
- Dexcom, Inc.$49
- Mylan Specialty L.p.$47
- plus $202 from 8 others
What the payments were for
- Food & beverage$836100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 11 | $295 |
| Lilly USA, LLC | 7 | $123 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $70 |
| GSK | 2 | $51 |
| Dexcom, Inc. | 1 | $49 |
| Mylan Specialty L.p. | 2 | $47 |
| Amgen | 3 | $43 |
| Astellas Pharma US Inc | 1 | $36 |
| Boehringer Ingelheim | 2 | $33 |
| Pfizer | 2 | $30 |
| Eisai Inc. | 1 | $19 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Corium, LLC | 1 | $11 |
How this compares
Too few family health providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 36 | $1,245 |
| Duloxetine Hcl | 21 | $644 |
| Gabapentin | 37 | $492 |
| Pregabalin | 24 | $426 |
| Mirtazapine | 31 | $367 |
| Alprazolam | 45 | $243 |
| Promethazine Hcl | 18 | $214 |
| Buspirone Hcl | 17 | $172 |
| Pantoprazole Sodium | 12 | $167 |
| Escitalopram Oxalate | 17 | $151 |
| Clonazepam | 15 | $105 |
| Cyclobenzaprine Hcl | 18 | $94 |
| Losartan Potassium | 12 | $84 |
Paid to pharmacies, not to this prescriber.
Other family health in Jonesboro
- Linda DukesHot Springs$7K
- Michelle AuldHot Springs$4K
- Jennifer JonesHot Springs$4K
- Sherry McCraryWynne$1K
- Marie Pham-RussellFort Smith$380
- Mirenda MartinSalem$48
- Holly TolhurstJacksonville$45
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.